Ad is loading...

GNFT Genfit SA Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases

Industry Biotechnology

Get AI intraday signals

GNFT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GNFT
(Try 14 days for Free)

View a ticker or compare two or three

Compare

GNFT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GNFT
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

GNFT is expected to report earnings to fall 177.79% to -45 cents per share on April 10

Q4'24

Est.

$-0.46

Q2'24

Beat

by $0.25

The last earnings report on September 19 showed earnings per share of 58 cents, beating the estimate of 33 cents. With 5.53K shares outstanding, the current market capitalization sits at 227.22M.

A.I. Advisor

published General Information

General Information

a developer of biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Parc Eurasante

Phone

+33 320164000

Employees

148

Web

https://www.genfit.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
COMVX	4.11	-0.01	-0.24%
Comstock Capital Value AAA
JDVAX	15.91	-0.12	-0.75%
JPMorgan Diversified A
GOGIX	27.08	-0.22	-0.81%
JHancock International Growth I
MDILX	18.81	-0.24	-1.26%
BlackRock International Inv A
DPTRX	42.56	-0.80	-1.85%
BNY Mellon Tax Managed Growth I

GNFT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GNFT has been loosely correlated with SPRB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GNFT jumps, then SPRB could also see price increases.

Ticker / NAME	Correlation To GNFT	1D Price Change %
GNFT	100%	-0.77%
SPRB - GNFT	39% Loosely correlated	-5.83%
BLPH - GNFT	28% Poorly correlated	N/A
PRME - GNFT	26% Poorly correlated	-6.95%
CVALF - GNFT	25% Poorly correlated	+6.35%
MRNA - GNFT	25% Poorly correlated	-7.34%
More